Suppr超能文献

结直肠癌肝转移患者的诊断评估与生存分析

Diagnostic evaluation and survival analysis of colorectal cancer patients with liver metastases.

作者信息

de Brauw L M, van de Velde C J, Bouwhuis-Hoogerwerf M L, Zwaveling A

出版信息

J Surg Oncol. 1987 Feb;34(2):81-6. doi: 10.1002/jso.2930340204.

Abstract

Clinical features and their prognostic value were evaluated in 83 colorectal cancer patients with liver metastasis. The clinical features analysed included presenting symptoms and signs, liver function tests, extent of liver involvement, associated extrahepatic tumor growth, and physical condition of the patients. Overall median survival time after diagnosis of liver metastases was 8.4 months. Prognostic factors related to survival were symptoms, when referable to liver metastasis, and 5' Nt. Information is supplied to survey what selection of patients should be considered for various treatment options. A predominance of the patients showed bilobar liver involvement (79.6%), extrahepatic tumor growth (49.4%), or had an unresectable primary tumor (30.1%), thus leaving only 6% of the patients with liver metastases for surgical treatment with the intention of cure.

摘要

对83例发生肝转移的结直肠癌患者的临床特征及其预后价值进行了评估。分析的临床特征包括出现的症状和体征、肝功能检查、肝脏受累程度、相关的肝外肿瘤生长情况以及患者的身体状况。诊断肝转移后的总体中位生存时间为8.4个月。与生存相关的预后因素是可归因于肝转移的症状和5′核苷酸酶。提供信息以调查对于各种治疗方案应考虑选择哪些患者。大多数患者表现为双侧肝脏受累(79.6%)、肝外肿瘤生长(49.4%)或有不可切除的原发肿瘤(30.1%),因此仅有6%发生肝转移的患者适合接受旨在治愈的手术治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验